Language
中文
한국어
日本語
English
Home
Contact Us
Sitemap
Login
Search for:
About APASL
History
Steering Committee
Executive Council
Committees
Working Parties
Advisors
APASL Conferences
Future Meetings of APASL
Annual Meetings
Single Topic Conferences
Picture Gallery
Membership
Privileges
Application Process
Subscription of Journal
Hepatology International
Subscription Process
Guidelines
APASL Award
Education
APASL Webinar
Training Institutions
School of Hepatology webinar
School of Hepatology
Education Program on Chronic Hepatitis Disease
Fellowship
Developing patient groups for viral hepatitis
APASL Casts
APASL Hepatology Webinar_ep5
Immune-tolerant phase: A remaining battlefield against hepatitis B
COVID-19 vaccination in patients with liver disease
Updates of Systemic Therapy for Hepatocellular Carcinoma
New drugs for hepatitis B under development
Mechanism and noninvasive assessment of liver fibrosis and steatosis
Microbiota and liver diseases
Updates of management for cirrhotic complications
Current and future management of NAFLD
Episode5-10
New approaches for personalized surveillance of hepatocellular carcinoma
APASL Hepatology Webinar_ep4
Variceal Bleeding and Portal Hypertension
Autoimmune Hepatitis
Drug-induced Liver Injury
Drug Development in Hepatitis B
Editor’s Choice: Journal of Hepatology
Editor’s Choice: Hepatology
“Targeted therapy for HCC”
“Case presentation in real life and how to move forward
APASL Hepatology Webinar 2020_ep3
The APASL Hepatology Webinar 3-1 has been successfully held!
The APASL Hepatology Webinar 3-2 has been successfully held!
The APASL Hepatology Webinar 3-3 has been successfully held!
The APASL Hepatology Webinar 3-4 has been successfully held!
The APASL Hepatology Webinar 3-5 has been successfully held!
The APASL Hepatology Webinar 3-6 has been successfully held!
The APASL Hepatology Webinar 3-7 has been successfully held!
The APASL Memorial Webinar has been successfully held!
APASL Hepatology Webinar 2020_ep2
The APASL Hepatology Webinar 2-1 has been successfully held!
The APASL Hepatology Webinar 2-2 has been successfully held!
The APASL Hepatology Webinar 2-3 has been successfully held!
The APASL Hepatology Webinar 2-4 has been successfully held!
The APASL Hepatology Webinar 2-5 has been successfully held!
The APASL Hepatology Webinar 2-6 has been successfully held!
The APASL Hepatology Webinar 2-7 has been successfully held!
APASL Hepatology Webinar 2020_ep1
Diagnosis and Treatment Protocol of COVID-19 in China
Who have saved the first American from Covid 19?
Liver injury in Covid 19
Liver transplantation perspective
How to manage HCC patients?
Hepatotoxicity of anti-Covid 19 therapy
To understand sytokine storm in COVID-19”
APASL2019
APASL2018
APASL2017
APASL2016
APASL2015
APASL2014
APASL STC 2020
APASL STC on Portal Hypertension in China has been successfully held!
APASL STC 2019
APASL STC 2018 in Beijing
APASL STC 2018 in Yokohama
Links & Notices
Related Meetings
Related Societies
Home
Headline
Elimination statement signed and shared with WHO, EASL, AASLD, and ALEH!
Elimination statement signed and shared with WHO, EASL, AASLD, and ALEH!
https://www.facebook.com/111174402293114/videos/1045554385521773/?fref=nf
![The Asian Pacific Association for the Study of the Liver [APASL]](http://apasl.info/app-def/S-102/apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}